Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 13, 2006

Articles

Favourites:
ADD
Favourites:
ADD

Target Organ Damage in Hypertension: Pathophysiology and Implications for Drug Therapy
pp. 1581-1592(12)
Authors: Nadar, Sunil K.; Tayebjee, Muzahir H.; Messerli, Franz; Lip, Gregory Y.H.

Favourites:
ADD

Novel Concepts of Statin Therapy for Cardiovascular Risk Reduction in Hypertension
pp. 1593-1609(17)
Authors: Varughese, George I.; Patel, Jeetesh V.; Lip, Gregory Y.H.; Varma, Chetan

Favourites:
ADD

Traditional Risk Factors for Coronary Atherosclerosis in Indo Asians: The Need for a Reappraisal
pp. 1611-1621(11)
Authors: Jaumdally, J. R.; Lip, Gregory Y.H.; Varma, Chetan

Favourites:
ADD

Is Hypertension an Inflammatory Process?
pp. 1623-1635(13)
Authors: Boos, Christopher J.; Lip, Gregory Y.H.

Favourites:
ADD

Emerging Therapeutic Potential of Whey Proteins and Peptides
pp. 1637-1643(7)
Author: Yalcin, A. S.

Favourites:
ADD

Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
pp. 1645-1680(36)
Authors: Marklund, Niklas; Bakshi, Asha; Castelbuono, Deborah J.; Conte, Valeria; McIntosh, Tracy K.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content